Logo image of BKHA

BLACK HAWK ACQUISITION COR-A (BKHA) Stock Fundamental Analysis

NASDAQ:BKHA - Nasdaq - KYG1148A1013 - Common Stock - Currency: USD

10.51  +0.01 (+0.1%)

Fundamental Rating

2

BKHA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. BKHA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. BKHA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BKHA was profitable.
In the past year BKHA has reported a negative cash flow from operations.
BKHA Yearly Net Income VS EBIT VS OCF VS FCFBKHA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 500K -500K 1M 1.5M

1.2 Ratios

Industry RankSector Rank
ROA 2.66%
ROE 2.75%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BKHA Yearly ROA, ROE, ROICBKHA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -100 -200 -300

1.3 Margins

BKHA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BKHA Yearly Profit, Operating, Gross MarginsBKHA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

6

2. Health

2.1 Basic Checks

Compared to 1 year ago, BKHA has more shares outstanding
BKHA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BKHA Yearly Shares OutstandingBKHA Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2M 4M 6M 8M
BKHA Yearly Total Debt VS Total AssetsBKHA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 20M 40M 60M

2.2 Solvency

An Altman-Z score of 22.59 indicates that BKHA is not in any danger for bankruptcy at the moment.
BKHA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 22.59
ROIC/WACCN/A
WACCN/A
BKHA Yearly LT Debt VS Equity VS FCFBKHA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 20M 40M 60M

2.3 Liquidity

BKHA has a Current Ratio of 4.42. This indicates that BKHA is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 4.42 indicates that BKHA has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 4.42
Quick Ratio 4.42
BKHA Yearly Current Assets VS Current LiabilitesBKHA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 100K 200K 300K

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 12004.17% over the past year.
EPS 1Y (TTM)12004.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BKHA Yearly Revenue VS EstimatesBKHA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024
BKHA Yearly EPS VS EstimatesBKHA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BKHA is valuated quite expensively with a Price/Earnings ratio of 50.05.
Compared to an average S&P500 Price/Earnings ratio of 29.35, BKHA is valued quite expensively.
Industry RankSector Rank
PE 50.05
Fwd PE N/A
BKHA Price Earnings VS Forward Price EarningsBKHA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BKHA Per share dataBKHA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

BKHA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BLACK HAWK ACQUISITION COR-A

NASDAQ:BKHA (3/7/2025, 8:07:46 PM)

10.51

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners70.25%
Inst Owner ChangeN/A
Ins Owners6.89%
Ins Owner ChangeN/A
Market Cap93.85M
AnalystsN/A
Price TargetN/A
Short Float %0.03%
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 50.05
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)0.21
EY2%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS7.8
TBVpS7.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.66%
ROE 2.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.42
Quick Ratio 4.42
Altman-Z 22.59
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12004.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2948.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-17761.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17761.3%
OCF growth 3YN/A
OCF growth 5YN/A